Aime Christian Kayath | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Aime Christian Kayath | Microbial Cell Biology | Best Researcher Award

Prof. Aime Christian Kayath, Marien NGOUABI University, Republic of the Congo

Dr. Christian Aimé Kayath is a Congolese biotechnologist, academic, and scientific leader with over two decades of experience in teaching, research, and science policy. Currently serving as the Director of Cooperation at the Ministry of Higher Education, Scientific Research and Technological Innovation (MESRSIT) in the Republic of Congo, he is also a CAMES-accredited Research Professor at Marien Ngouabi University. With a strong foundation in microbiology, molecular biology, and biotechnology, Dr. Kayath has authored over 70 peer-reviewed publications and supervised more than 100 dissertations. His research spans bioremediation, biosurfactants, and fermented food technology. A multilingual scholar fluent in French and English, he has also held research and teaching roles in Belgium, significantly shaping Congo’s scientific infrastructure. He is known for his dedication to academic excellence and public science engagement, as reflected in his creation of educational movements and leadership in cultural organizations.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. 🔬 Robust Research Output

    • 71 peer-reviewed journal articles, 1 book, and 10+ supervised theses.

    • h-index of 9, with 311 citations and a Research Interest Score of 526.8 on ResearchGate.

    • Published consistently in reputable journals like International Journal of Microbiology and Journal of Pathogens.

  2. 👨‍🏫 Academic & Mentorship Leadership

    • Over 100 dissertations supervised since 2015, showing commitment to academic mentorship.

    • Active as a CAMES Lecturer, Research Professor, and Head of a Research Laboratory.

  3. 🌍 International & Policy Experience

    • Held senior roles in government ministries (MRSIT, MESRSIT) as Director of Cooperation and Scientific Activities.

    • Experience across Congo and Belgium, including universities and research institutes.

    • Served as National Liaison Officer (NLO) with the IAEA (2014–2023), indicating global collaboration in science and technology.

  4. 📚 Multidisciplinary Expertise

    • Specialized in biotechnology, molecular biology, microbiology, and biosurfactants.

    • Also skilled in e-management, IT tools, and web design, showcasing adaptability and cross-functional capabilities.

  5. 🫂 Community & Social Engagement

    • Founder of the social education movement “L’école ke bien, l’école ke futa” to fight school dropouts.

    • President of a historic choir with 200+ members, highlighting leadership in civil society.

⚠️ Areas for Improvement:

  • 🌐 Global Collaboration Expansion

    • Although strong in Africa and Europe, expanding collaborations to North America or Asia could enhance his global academic influence.

  • 📱 Digital Visibility

    • A dedicated academic website, active LinkedIn profile, or Google Scholar page would improve public and institutional access to his achievements.

  • 🎯 Citation and Impact

    • While his h-index (9) and citation count (311) are respectable, targeting high-impact journals could elevate his academic footprint further.

🎓 Education:

Dr. Kayath’s academic journey began at Marien Ngouabi University (Congo) with a Bachelor’s degree in Cell Biology and Physiology (1999–2000), followed by a Master’s in Cellular and Molecular Biology (2000–2001). He later pursued a DES in Biotechnology with Distinction at the University of Liège, Belgium (2003–2005), before completing a PhD in Biotechnology–Biochemistry–Molecular Biology (2005–2010), where he graduated with honors. His education is enhanced by complementary training in e-management and business administration (2008–2009, Brussels), which supports his administrative expertise. Dr. Kayath has consistently merged academic rigor with applied science and policy, reflecting a versatile and forward-thinking scholar. His multidisciplinary background underpins his work in biosciences, research governance, and international cooperation.

💼 Professional Experience:

Dr. Kayath’s career includes significant roles in academia, research, and science governance. He has served as Research Professor and Head of Laboratory of Applied Microbiology and Molecular Biology at IRSEN/MESRSIT since 2014. He was previously Scientific Attaché (2015–2016), Director of Scientific Activities (2019–2021), and currently serves as Director of Cooperation at MESRSIT. Internationally, he worked in Belgium as a Senior Scientist at Ovogenics (2011–2012), Project Developer at CERP Haren (2010–2011), and Assistant Professor at the University of Brussels (2008–2011). Earlier, he taught biology at Lycée Ecole Actuel and the International University of Brazzaville. He also acted as NLO for the IAEA (2014–2023), enhancing nuclear science cooperation. His professional path showcases a strong alignment between scientific leadership and practical impact.

🔬 Research Focus:

Dr. Kayath’s research specializes in microbial biotechnology, with a focus on biosurfactant production, bioremediation, microbial fermentation, and pathogen control. His investigations explore the role of indigenous Bacillus strains in soil cleanup and food preservation, alongside the biomedical enhancement of fermented products. He has studied Shigella flexneri’s biosurfactant mechanisms, polyphenol enhancement in ginger fermentation, and biosurfactants in plantain wine. His research directly addresses health, food security, and environmental issues in Sub-Saharan Africa and beyond. Dr. Kayath integrates molecular biology, biochemistry, and microbial ecology, often applying meta-analytical techniques and PCR methods. His ability to blend applied research with policy has made him a bridge between science and governance, reinforcing national research strategies in Congo. His work is widely cited, and he continues to contribute to sustainable innovation in African biotechnology.

📚 Publications Top Notes: 

  1. 🧫 High Efficacy of Rose Bengal in Reducing the Pathogenicity of Escherichia coli – Int. J. of Microbiology (2025)

  2. 🍛 Evolution of Fermented Food Products in the Republic of Congo: A Meta-analytic Review – J. of Advances in Microbiology (2024)

  3. 🌱 Bacillus Species Consortium as a New Starter in Cassava Retting – Int. J. of Microbiology & Biotechnology (2024)

  4. 🧪 Involvement of Bacillus SecYEG Pathway in Biosurfactant Production and Biofilm Formation – Int. J. of Microbiology (2024)

  5. 🛢 Profiling of Indigenous Biosurfactant-Producing Bacillus Isolates in Bioremediation – Int. J. of Microbiology (2021)

  6. 🔬 Prime Enzymatic Exocellular Background of Lysinibacillus louembei – Advances in Microbiology (2020)

  7. 🍹 Synergic Involvements of Microorganisms in Fermented Ginger Juice – Int. J. of Microbiology (2020)

  8. 🧫 Invasion of Epithelial Cells via T3SS of Shigella flexneri – J. of Pathogens (2020)

  9. 🧬 Invasion of Epithelial Cells via T3SS of Shigella flexneri (Preprint) – bioRxiv (2020)

  10. 🍷 Benefits of Biosurfactants from Lactic Acid Bacteria in Plantain Wine – Advances in Microbiology (2019)

🧾 Conclusion:

Dr. Christian Aimé Kayath is an exceptionally qualified and well-rounded researcher, merging high-level academic output with administrative leadership and societal engagement. His prolific publication record, contribution to education policy, international collaborations, and mentorship excellence make him highly suitable for the Best Researcher Award.

Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Published on by Cell Biologist

Prof. Dr. Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Prof. Dr. Hatice Yesim Karasulu , Ege University, Faculty of Pharmacy, Pharmaceutical Technology , Turkey

Prof. Dr. H. Yeşim Karasulu is a distinguished academic and researcher in pharmaceutical technology, based at Ege University in Turkey. With a career spanning decades, she earned her Ph.D. in Pharmaceutical Technology from Ege University, where she became an Associate Professor in 2006 and a full Professor in 2011. Prof. Karasulu has held numerous positions, including consultant for the Ege University Center for Drug Research & Development (ARGEFAR) and member of the pharmaceutical technology commission at Turkey’s Ministry of Health from 2006 to 2024. She has contributed extensively to drug delivery systems and pharmaceutical formulations, especially focusing on colloidal drug delivery. Over the years, she has published over 50 research papers, authored five book chapters, and is the holder of two patents related to nano-drug delivery systems. Her work has advanced both academic knowledge and pharmaceutical industry practices.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Experience: Prof. Dr. H. Yeşim Karasulu has an exceptional track record with more than 50 publications, multiple patents, and ongoing research projects. Her innovative work in colloidal drug delivery systems, including liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS), positions her as a leading researcher in the pharmaceutical field.
  2. High Impact and Collaboration: Her research is widely cited with an H-index of 16 (WoS) and 18 (Scopus). She has collaborated with prestigious institutions such as the University of Vienna and the Aristotle University of Thessaloniki, further enhancing the global impact of her work.
  3. Patent and Industry Collaboration: Prof. Karasulu’s research has led to two patents and several patent applications, showcasing the practical and commercial value of her innovations. Additionally, her collaborative efforts with the pharmaceutical industry in developing drug delivery systems highlight her ability to bridge academia and industry, enhancing the potential for real-world applications.
  4. Ongoing Research Projects: Prof. Karasulu is involved in multiple research projects, both academic and industry-sponsored, demonstrating her continuous commitment to advancing pharmaceutical sciences. Her ongoing projects include drug delivery systems targeting specific organs and improving drug bioavailability and stability.
  5. Awards and Recognition: Prof. Karasulu’s achievements are recognized through awards such as the Ege ArGe First Prize and the Ege ArGe Innovation Award, confirming the innovative nature of her research.

Areas for Improvement:

  1. Broader International Visibility: While Prof. Karasulu has a strong track record within her field, expanding her international visibility by increasing collaborations with leading global pharmaceutical companies could further enhance the global reach and impact of her innovations.
  2. Diversity of Published Works: Though Prof. Karasulu has an impressive number of publications, exploring opportunities for publication in high-impact journals outside her primary research focus could enhance her visibility in other areas of pharmaceutical sciences.
  3. Focus on Translational Research: While there is a strong emphasis on preclinical studies and formulation development, further focus on clinical trials and commercialization of her innovations could enhance the practical application of her work, especially with regard to regulatory approval processes for new drug delivery systems.

Education:

Prof. Dr. H. Yeşim Karasulu pursued her academic studies at Ege University in Izmir, Turkey. She completed her Bachelor’s degree in Pharmacy at the Faculty of Pharmacy before obtaining a Ph.D. in Pharmaceutical Technology from the same institution. Her education continued with postdoctoral research at the University of Vienna, focusing on Pharmaceutical Technology and Biopharmaceutics under the guidance of Prof. Dr. Franz Gabor. This international research experience allowed her to expand her expertise in colloidal drug delivery systems, setting the foundation for her career as a researcher. Throughout her education, Prof. Karasulu’s work has concentrated on the development of drug delivery systems, with an emphasis on enhancing the bioavailability and targeting of drugs using innovative methods like liposomes, nano/microparticles, and microemulsions. Her academic background has enabled her to contribute significantly to both research and industry practices in pharmaceutical sciences.

Experience:

Prof. Dr. H. Yeşim Karasulu has a distinguished career in both academia and the pharmaceutical industry. She began her academic career as a faculty member at Ege University, where she progressed from an Assistant Professor to a full Professor in the Department of Pharmaceutical Technology. Additionally, she has been an active consultant at the Ege University Center for Drug Research & Development (ARGEFAR) since 2011. Prof. Karasulu also served as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency between 2006 and 2024, helping shape national pharmaceutical policies. Her extensive research has led to breakthroughs in nano-drug delivery systems, contributing to the development of two patents and several industry projects. She has worked on numerous national and international projects focusing on drug formulation, bioavailability enhancement, and targeting systems, particularly for cancer therapy and chronic diseases.

Research Focus:

Prof. Dr. H. Yeşim Karasulu’s research primarily focuses on the development and evaluation of advanced colloidal drug delivery systems. Her work spans liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS). These innovative systems aim to enhance the bioavailability, stability, and targeted delivery of pharmaceutical compounds. Prof. Karasulu has led several high-impact research projects funded by both national (TUBİTAK) and international bodies, such as the European Union. Her research is dedicated to improving the therapeutic efficacy of drugs, particularly in challenging areas like cancer treatment and chronic diseases. Prof. Karasulu’s work is closely aligned with real-world applications, as evidenced by her ongoing collaboration with the pharmaceutical industry to bring new drug delivery systems to market. Her goal is to create formulations that not only improve patient outcomes but also contribute to the overall advancement of pharmaceutical technology.

Publications Top Notes:

  1. “Degradation and gastrointestinal stability of nitrofurantoin in acidic and alkaline media” 📉💊
  2. “Sustained-release dosage form of nitrofurantoin: Part 1. Preparation of microcapsules and in vitro release kinetics” 💊🔬
  3. “33 factorial design-based optimization of the formulation of nitrofurantoin microcapsules” 🔬📊
  4. “In vitro-in vivo correlations of nitrofurantoin matrix tablet formulation” 💊⚖️
  5. “A New In Vitro/In Vivo Kinetic Correlation Method for Nitrofurantoin Matrix Tablet Formulations” 🧪💡
  6. “Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery” 💊💥
  7. “Different geometric shaped hydrogel theophylline tablets: Statistical approach for estimating drug release” 💊📐
  8. “Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates” 💊🔢
  9. “Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets” 🧪📊
  10. “Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida Albicans” 💊🦠
  11. “Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line” 🔬🧪
  12. “In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin” 💊🐇
  13. “Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line” 🔬💉
  14. “Transdermal delivery of diclofenac sodium through rat skin from various formulations” 💊🦷
  15. “Controlled release of methotrexate from W/O microemulsion and its in vitro anti-tumor activity” 🧪💥

Conclusion:

Prof. Dr. H. Yeşim Karasulu is a highly deserving candidate for the Best Innovation Award. Her groundbreaking research in colloidal drug delivery systems has significantly contributed to advancements in pharmaceutical sciences. With numerous publications, patents, and collaborations, her work not only pushes the boundaries of scientific research but also has a profound impact on drug development. By focusing on broader international collaborations and further developing translational research strategies, Prof. Karasulu’s contributions to the pharmaceutical industry and academic community will continue to grow, solidifying her place as a leader in innovation.